Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities

Por Amorij, J-P., Huckriede, A., Wilschut, J., Frijlink, H. W., Hinrichs, W. L. J.
Publicado em 2008

Development and Application of a Process Window for Achieving High-Quality Coating in a Fluidized Bed Coating Process

Por Laksmana, F. L., Hartman Kok, P. J. A., Vromans, H., Frijlink, H. W., Van der Voort Maarschalk, K.
Publicado em 2009

Thermal Gradient Mid- and Far-Infrared Spectroscopy as Tools for Characterization of Protein Carbohydrate Lyophilizates

Por Mensink, M. A., Šibík, J., Frijlink, H. W., van der Voort Maarschalk, K., Hinrichs, W. L. J., Zeitler, J. A.
Publicado no Mol Pharm (2017)

Relative Bioavailability of Three Newly Developed Albendazole Formulations: a Randomized Crossover Study with Healthy Volunteers

Por Rigter, I. M., Schipper, H. G., Koopmans, R. P., Kan, H. J. M. van, Frijlink, H. W., Kager, P. A., Guchelaar, H.-J.
Publicado em 2004

Can Patients with Parkinson’s Disease Use Dry Powder Inhalers during Off Periods?

Por Luinstra, M., Rutgers, A. W. F., Dijkstra, H., Grasmeijer, F., Hagedoorn, P., Vogelzang, J. M. J., Frijlink, H. W., de Boer, A. H.
Publicado no PLoS One (2015)